Inspire Medical Systems (INSP) Stock Statistics & Valuation Metrics

Inspire Medical Systems has a market cap or net worth of $1.68B. The enterprise value is $1.66B.

Inspire Medical Systems has 28,589,290 shares outstanding. The number of shares has decreased by -2.65% in one year.

Inspire Medical Systems’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 6.26%.

The current PE Ratio of Inspire Medical Systems is 18.6. Inspire Medical Systems’s PEG ratio is 0.11.

In the last 12 months, Inspire Medical Systems had revenue of 911.98M and earned 145.42M in profits. Earnings per share was 4.95.

In the last 12 months, operating cash flow was 116.98M and capital expenditures -38.50M, giving a free cash flow of 78.48M billion.

Inspire Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―

Inspire Medical Systems upcoming earnings date is May 5, 2026, After Close (Confirmed).

Inspire Medical Systems as a current ratio of 6.08, with Debt / Equity ratio of 7.96%

In the past 12 months, Inspire Medical Systems has paid -79.72M in taxes.

Inspire Medical Systems EV to EBITDA ratio is 40.61, with an EV/FCF ratio of 33.59.

Inspire Medical Systems has $308.27M in cash and marketable securities with $62.15M in debt, giving a net cash position of $246.12M billion.

Gross margin is 85.39%, with operating margin of 5.59%, and net profit margin of 15.95%.

The average price target for Inspire Medical Systems is $77.82, which is 11.43% higher than the current price. The consensus rating is Hold